Company Overview
- Headquarters
- 257 S 25th St, Philadelphia PA
- Website
- reunionneuro.com
- Employees
- 22
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is Reunion Neuroscience
Reunion Neuroscience is a biotechnology company headquartered in Philadelphia, Pennsylvania. The company employs 22 individuals and generates an annual revenue of $2.5 million. Reunion Neuroscience is publicly traded on the NASDAQ stock exchange under the ticker symbol REUN. Reunion Neuroscience focuses on developing innovative therapeutic solutions for mental health conditions. Their core research centers around the creation of novel psychedelic compounds with the potential to treat a range of mental health disorders. Reunion Neuroscience distinguishes itself through its commitment to scientific rigor and its focus on developing next-generation psychedelic therapies. The company leverages cutting-edge research and development capabilities to advance its pipeline of novel compounds. Interested parties can learn more about Reunion Neuroscience and its work by visiting their website at reunionneuro.com.
Company Leadership
Reunion Neuroscience Industry Tags
Companies Similar to Reunion Neuroscience
Analyze industry trends and opportunities by examining competitors and companies comparable to Reunion Neuroscience, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |